A Trial of Bioheart's Adipose-derived, Autologous Stem Cell Therapy (AdipoCell) for Congestive Heart Failure

Trial Profile

A Trial of Bioheart's Adipose-derived, Autologous Stem Cell Therapy (AdipoCell) for Congestive Heart Failure

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 07 Jul 2014

At a glance

  • Drugs Adipose-derived-autologous-stem-cell-therapy-U.S.-Stem-Cell (Primary)
  • Indications Heart failure
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Revita Life Sciences; U.S. Stem Cell
  • Most Recent Events

    • 07 Jul 2014 According to the BioHeart Inc media release, one patient has been enrolled in this trial.
    • 07 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top